AltPep
Chuck previously held executive and managerial roles in tech companies such as Dell Computer and Silicon Graphics, and was part of the executive team that turned around Safeco Corporation. In recent years he’s invested, advised, and served as CFO in startup companies before joining AltPep.
This person is not in any offices
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).